Suppr超能文献

肝移植术后胆道漏使用全覆膜自膨式金属胆道支架后狭窄发生率升高。

Elevated stricture rate following the use of fully covered self-expandable metal biliary stents for biliary leaks following liver transplantation.

机构信息

Department of Surgery, University of Virginia Health System, Charlottesville, Virginia 22908-0708, USA.

出版信息

Endoscopy. 2011 Jun;43(6):512-7. doi: 10.1055/s-0030-1256389. Epub 2011 May 26.

Abstract

BACKGROUND

Biliary leaks and strictures are common complications after liver transplantation and can be managed surgically or endoscopically. Endoscopic management using fully covered self-expandable metal stents (FCSEMS) might provide some advantages over the commonly used plastic stents in the management of bile leaks after liver transplantation.

METHODS

Between December 2006 and January 2009, 17 liver transplant recipients underwent placement of a FCSEMS for treatment of biliary leaks.

RESULTS

FCSEMS were deployed at median of 18 days (range: 6 - 160) after liver transplantation and left in place for a median of 102 days (range: 35 - 427), with a median follow-up after FCSEMS removal of 407 days (range: 27 - 972). Long-term leak control was obtained in all but one patient. Complications included 6 clinically significant biliary strictures (35 %), which were treated with repeat stent placement, and two clinically insignificant strictures (12 %) which required no intervention. Additionally, three patients (18 %) had biliary ulcerations after stent removal, confirmed by choledochoscopy, and were managed conservatively. Two patients required repeat liver transplantation due to hepatic artery thrombosis, and one patient died from sepsis unrelated to FCSEMS stenting.

CONCLUSIONS

FCSEMS treat biliary leaks effectively, but carry a relatively high stricture risk in patients who have received liver transplants. FCSEMS cannot be recommended for management of biliary leaks following liver transplantation at this point.

摘要

背景

胆漏和狭窄是肝移植后的常见并发症,可以通过手术或内镜进行治疗。与常用的塑料支架相比,全覆膜自膨式金属支架(FCSEMS)在内镜治疗肝移植后胆漏方面可能具有一些优势。

方法

2006 年 12 月至 2009 年 1 月,17 例肝移植患者接受 FCSEMS 置入治疗胆漏。

结果

FCSEMS 在肝移植后中位 18 天(范围:6-160 天)置入,中位留置时间为 102 天(范围:35-427 天),FCSEMS 取出后中位随访时间为 407 天(范围:27-972 天)。除 1 例患者外,所有患者均获得长期漏口控制。并发症包括 6 例(35%)有临床意义的胆管狭窄,采用再次支架置入治疗,2 例(12%)无临床意义的狭窄无需干预。此外,3 例(18%)患者在支架取出后出现胆管溃疡,经胆管镜检查证实,并保守治疗。2 例患者因肝动脉血栓形成需要再次肝移植,1 例患者因与 FCSEMS 支架置入无关的败血症死亡。

结论

FCSEMS 可有效治疗胆漏,但在接受肝移植的患者中,其狭窄风险相对较高。目前不推荐 FCSEMS 用于肝移植后胆漏的治疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验